Hedge Fund - OrbiMed Advisors
Biogen Inc. (BIIB)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2024 - Q4 (2024-12-31) | $77,851,572 | 1.6% | 509,100 | $168.67 |
| 2 | 2024 - Q3 (2024-09-30) | $157,591,920 | 2.86% | 813,000 | $209.21 |
| 3 | 2024 - Q2 (2024-06-30) | $208,846,638 | 4.12% | 900,900 | $217.32 |
| 4 | 2024 - Q1 (2024-03-31) | $194,261,067 | 3.55% | 900,900 | $234.20 |
| 5 | 2023 - Q4 (2023-12-31) | $214,158,052 | 4.27% | 827,600 | $245.62 |
| 6 | 2023 - Q3 (2023-09-30) | $143,103,168 | 3.03% | 556,800 | $267.47 |
| 7 | 2023 - Q2 (2023-06-30) | $158,604,480 | 2.87% | 556,800 | $297.84 |
| 8 | 2023 - Q1 (2023-03-31) | $140,405,150 | 2.75% | 505,000 | $276.70 |
| 9 | 2022 - Q4 (2022-12-31) | $71,500,744 | 1.36% | 258,200 | $282.44 |
| 10 | 2022 - Q3 (2022-09-30) | $59,968,000 | 1.11% | 224,600 | $212.38 |
| 11 | 2022 - Q2 (2022-06-30) | $22,760,000 | 0.41% | 111,600 | $204.43 |
| 12 | 2022 - Q1 (2022-03-31) | $24,830,000 | 0.4% | 117,900 | $217.46 |
| 13 | 2021 - Q4 (2021-12-31) | $55,230,000 | 0.71% | 230,200 | $257.12 |
| 14 | 2021 - Q3 (2021-09-30) | $66,276,000 | 0.72% | 234,200 | $327.75 |
| 15 | 2021 - Q2 (2021-06-30) | $23,339,000 | 0.23% | 67,400 | $302.94 |
| 16 | 2021 - Q1 (2021-03-31) | $22,940,000 | 0.21% | 82,000 | $269.69 |
| 17 | 2020 - Q4 (2020-12-31) | $129,629,000 | 1.13% | 529,400 | $259.08 |
| 18 | 2020 - Q3 (2020-09-30) | $203,087,000 | 2.55% | 715,900 | $278.91 |
| 19 | 2020 - Q2 (2020-06-30) | $191,539,000 | 2.69% | 715,900 | $300.59 |
| 20 | 2020 - Q1 (2020-03-31) | $151,989,000 | 2.55% | 480,400 | $303.47 |
| 21 | 2019 - Q4 (2019-12-31) | $19,139,000 | 0.27% | 64,500 | $277.46 |
| 22 | 2019 - Q3 (2019-09-30) | $8,428,000 | 0.15% | 36,200 | $232.85 |
| 23 | 2019 - Q2 (2019-06-30) | $20,510,000 | 0.31% | 87,700 | $230.90 |
| 24 | 2019 - Q1 (2019-03-31) | $20,731,000 | 0.32% | 87,700 | $314.89 |
| 25 | 2018 - Q4 (2018-12-31) | $251,343,000 | 4.64% | 835,249 | $319.14 |
| 26 | 2018 - Q3 (2018-09-30) | $321,618,000 | 3.87% | 910,300 | $344.30 |
| 27 | 2018 - Q2 (2018-06-30) | $338,971,000 | 4.04% | 1,167,900 | $281.15 |
| 28 | 2018 - Q1 (2018-03-31) | $284,882,000 | 3.53% | 1,040,400 | $310.41 |
| 29 | 2017 - Q4 (2017-12-31) | $392,064,000 | 4.95% | 1,230,700 | $320.80 |
| 30 | 2017 - Q3 (2017-09-30) | $510,386,000 | 4.87% | 1,630,000 | $296.11 |
| 31 | 2017 - Q2 (2017-06-30) | $442,317,000 | 4.63% | 1,630,000 | $264.42 |
| 32 | 2017 - Q1 (2017-03-31) | $392,877,000 | 4.45% | 1,436,900 | $282.75 |
| 33 | 2016 - Q4 (2016-12-31) | $363,323,000 | 4.62% | 1,281,200 | $296.43 |
| 34 | 2016 - Q3 (2016-09-30) | $417,551,000 | 4.75% | 1,333,900 | $296.18 |
| 35 | 2016 - Q2 (2016-06-30) | $362,827,000 | 3.78% | 1,500,400 | $263.54 |
| 36 | 2016 - Q1 (2016-03-31) | $397,326,000 | 4.18% | 1,526,300 | $264.15 |
| 37 | 2015 - Q4 (2015-12-31) | $441,910,000 | 4% | 1,442,500 | $287.35 |
| 38 | 2015 - Q3 (2015-09-30) | $381,512,000 | 3.85% | 1,307,400 | $330.23 |
| 39 | 2015 - Q2 (2015-06-30) | $516,599,000 | 4.31% | 1,278,900 | $401.33 |
| 40 | 2015 - Q1 (2015-03-31) | $509,559,000 | 4.34% | 1,206,800 | $394.14 |
| 41 | 2014 - Q4 (2014-12-31) | $507,376,000 | 4.84% | 1,494,700 | $323.51 |
| 42 | 2014 - Q3 (2014-09-30) | $393,697,000 | 4.11% | 1,190,100 | $329.72 |
| 43 | 2014 - Q2 (2014-06-30) | $341,859,000 | 4.01% | 1,084,200 | $300.97 |
| 44 | 2014 - Q1 (2014-03-31) | $324,436,000 | 3.98% | 1,060,700 | $317.43 |
| 45 | 2013 - Q4 (2013-12-31) | $306,159,000 | 4.49% | 1,095,100 | $258.65 |
| 46 | 2013 - Q3 (2013-09-30) | $247,116,000 | 4.4% | 1,026,400 | $223.81 |
| 47 | 2013 - Q2 (2013-06-30) | $220,752,000 | 4.67% | 1,025,800 | $213.68 |
| 48 | 2013 - Q1 (2013-03-31) | $136,720,000 | 3.17% | 709,800 | $161.63 |
| 49 | 2012 - Q4 (2012-12-31) | $115,676,000 | 3.56% | 790,300 | $147.07 |
| 50 | 2012 - Q3 (2012-09-30) | $117,891,000 | 3.38% | 790,100 | $147.13 |
| 51 | 2012 - Q1 (2012-03-31) | $92,534,000 | 2.74% | 734,400 | $118.81 |
| 52 | 2011 - Q4 (2011-12-31) | $54,893,000 | 1.8% | 498,800 | $109.04 |
| 53 | 2011 - Q3 (2011-09-30) | $17,633,000 | 0.65% | 189,300 | $97.12 |
| 54 | 2011 - Q2 (2011-06-30) | $19,887,000 | 0.36% | 186,000 | $93.03 |
| 55 | 2011 - Q1 (2011-03-31) | $13,210,000 | 0.44% | 179,800 | $68.26 |
| 56 | 2010 - Q4 (2010-12-31) | $19,491,000 | 0.7% | 290,700 | $63.25 |
The displayed share prices are average quarterly stock market prices.